Similar articles for PMID: 24717411

Year	Number of Results
1995	1
1997	3
1998	4
1999	2
2000	6
2001	5
2002	1
2003	3
2004	5
2005	9
2006	5
2007	4
2008	7
2009	9
2010	5
2011	8
2012	8
2013	7
2014	13
2015	7
2016	5
2017	4
2018	5
2019	6
2020	5
2021	8
2022	8
2023	3
2024	0

1

Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.

Chauhan H, Killinger BA, Miller CV, Moszczynska A. Chauhan H, et al. Int J Mol Sci. 2014 Apr 8;15(4):5884-906. doi: 10.3390/ijms15045884. Int J Mol Sci. 2014. PMID: 24717411 Free PMC article.

2

Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.

Hadlock GC, Baucum AJ 2nd, King JL, Horner KA, Cook GA, Gibb JW, Wilkins DG, Hanson GR, Fleckenstein AE. Hadlock GC, et al. J Pharmacol Exp Ther. 2009 Apr;329(1):169-74. doi: 10.1124/jpet.108.145631. Epub 2009 Jan 13. J Pharmacol Exp Ther. 2009. PMID: 19141713 Free PMC article.

3

Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation.

Hadlock GC, Chu PW, Walters ET, Hanson GR, Fleckenstein AE. Hadlock GC, et al. J Pharmacol Exp Ther. 2010 Oct;335(1):207-12. doi: 10.1124/jpet.110.166660. Epub 2010 Jul 9. J Pharmacol Exp Ther. 2010. PMID: 20622144 Free PMC article.

4

Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.

Liu B, Traini R, Killinger B, Schneider B, Moszczynska A. Liu B, et al. Exp Neurol. 2013 Sep;247:359-72. doi: 10.1016/j.expneurol.2013.01.001. Epub 2013 Jan 9. Exp Neurol. 2013. PMID: 23313192 Free PMC article.

5

Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.

Bjorklund NL, Sorg BA, Schenk JO. Bjorklund NL, et al. Synapse. 2008 Oct;62(10):736-45. doi: 10.1002/syn.20528. Synapse. 2008. PMID: 18651643

6

Rapid and reversible effects of methamphetamine on dopamine transporters.

Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR. Fleckenstein AE, et al. J Pharmacol Exp Ther. 1997 Aug;282(2):834-8. J Pharmacol Exp Ther. 1997. PMID: 9262348

7

Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.

Killinger BA, Moszczynska A. Killinger BA, et al. J Neurochem. 2016 Feb;136(3):510-25. doi: 10.1111/jnc.13391. Epub 2015 Dec 10. J Neurochem. 2016. PMID: 26465779 Free PMC article.

8

Methamphetamine self-administration causes persistent striatal dopaminergic alterations and mitigates the deficits caused by a subsequent methamphetamine exposure.

McFadden LM, Hadlock GC, Allen SC, Vieira-Brock PL, Stout KA, Ellis JD, Hoonakker AJ, Andrenyak DM, Nielsen SM, Wilkins DG, Hanson GR, Fleckenstein AE. McFadden LM, et al. J Pharmacol Exp Ther. 2012 Feb;340(2):295-303. doi: 10.1124/jpet.111.188433. Epub 2011 Oct 27. J Pharmacol Exp Ther. 2012. PMID: 22034657 Free PMC article.

9

Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.

Gross NB, Duncker PC, Marshall JF. Gross NB, et al. Synapse. 2011 Nov;65(11):1144-55. doi: 10.1002/syn.20952. Epub 2011 Aug 31. Synapse. 2011. PMID: 21584865

10

Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.

German CL, Hanson GR, Fleckenstein AE. German CL, et al. J Neurochem. 2012 Oct;123(2):288-97. doi: 10.1111/j.1471-4159.2012.07875.x. Epub 2012 Aug 23. J Neurochem. 2012. PMID: 22804716 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

132 results

Results by year